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Abstract
               The role of tilt table testing as a diagnostic modality in children with unexplained 
syncope is unclear.   We sent a questionnaire to members of the Pediatric and Congenital 
Electrophysiology Society to assess the current practice pattern. Of the 186 members, 97 (52%) 
replied.   Twenty four percent of the pediatric electrophysiologists have completely stopped 
doing tilt table tests and of those performing the tests, a majority (76%) did < 10 tests/yr 
(median=3 tilts/yr, range 0-100/yr).  Of those performing the test, 95% rarely or never accepted 
direct referrals from the general practioners and 62% felt that the frequency of tilt table tests 
being performed had decreased since they had started practicing. The median usefulness of the 
test was rated at 3 (range 1-9) on a scale of 1 to 10 with 10 being very useful. A majority (68%) 
felt they rarely or never altered treatment based on the results of the tilt test.  Wide variability 
was noted in the test protocol including the tilt angle, tilt duration, use of pharmacologic agents 
and the duration of fasting prior to the test. We therefore conclude that there is significant lack of 
standardization in tilt table tests performed in children. Tilt table testing, as perceived by 
pediatric electrophysiologists, is of limited utility and progressively less used in children with 
syncope.
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Introduction
               Syncope is defined as a transient loss of consciousness and postural tone due to 
inadequate   cerebral   circulation.   It   is   a   common   and   often   frustrating   clinical   problem 
encountered by pediatricians in outpatient or emergency room settings. Neurocardiogenic 
syncope is believed to be the most common cause of syncope in the absence of structural heart 
disease1-3.  It is estimated that up to 15% of children will experience a syncopal episode before 
the   end   of   adolescence4.                                                                  
            Historically, the determination of neurocardiogenic syncope was made in the presence of 
a classic clinical history and after the exclusion of other causes of syncope. The use of tilt table 
testing for evaluation of syncope became widely popular in the 1990s after the publication of 
several key studies5-8. The American College of Cardiology published guidelines in 1996 on the 
indications of tilt table testing9. The general agreement was that tilt table testing should be done 
in patients with recurrent syncope or in high risk patients after a single syncopal  episode.  These 
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guidelines were based on studies done mostly in adults2.                                                          
            Initial studies in children found the head-up tilt test to be a useful tool for investigating 
neurally mediated syncope10-12. Over the last decade, however, the utility of tilt table testing for 
evaluation   of   pediatric   syncope   has   been   increasingly   questioned13-17.   As   pediatric 
electrophysiologists (EPs) are the most likely subset of physicians dealing with syncope in 
children, we designed a questionnaire directed at them to better understand the current practice 
of tilt table testing in patients with syncope.                                                                            
Materials   and   Methods                                                                                    
            We sent a 24-question survey to physician members of the Pediatric and Congenital 
Electrophysiology Society (PACES) to assess the current practice pattern. These 24 questions 
addressed issues regarding the frequency, trends, and methods and perceived utility of tilt table 
tests (Table 1). Individual physicians, rather than institutions were surveyed. The numbers in the 
results section are based on estimates reported by individual physicians. The study was approved 
by the institutional review board at the University of California-Irvine and by the executive 
board of PACES. All values are expressed as medians. Statistical analyses were done with paired 
t tests. Significance was accepted at P ≤ 0.05.
Table 1: TILT TABLE TEST - Questionnaire
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 8 (4): 242-246 (2008)Anjan S. Batra, MD, Seshadri Balaji, “Usefulness of Tilt Testing in Children                244 
with Syncope: A Survey of Pediatric Electrophysiologists”
Results
               Of the 186 PACES members worldwide, 97 (52%) participated in the study. The 
pediatric EPs responding had been in practice for a median of 12 years (range 1 - 27 years) and 
practiced in groups with a median of 10 cardiologists (range 1-45).  Twenty four percent of the 
pediatric EPs have completely stopped doing tilt table tests and of those performing the tests, a 
majority (76%) did < 10 tests/yr (median=3 tilts/yr, range 0-100/yr).  Of those performing the 
test, 95% rarely or never accepted direct referrals from the general practioners for tilt table tests 
and 62% felt that the frequency of tilt table tests being performed had decreased since they had 
started   practicing.                                                                      
            Medications used to enhance the sensitivity of the test included isoproterenol (79%), 
nitroglycerine (5%) and other miscellaneous drugs (16%). Those who performed the test used a 
variety of tilt angles [60° (24%), 70° (36%), 80° (36%), 90° (1%), and variable (3%)]. Likewise, 
there was wide variation in the duration of tilting before declaring it negative [< 10 min (4%), 
10-15 min (14%), 16-20 min (26%), 21-25 min (18%), >25 min (36%) variable (2%)]. The 
duration of fasting (nothing by mouth status) before the test was also variable [< 2 hours (18%), 
2-4 hours (47%), > 4 hours (19%), variable (16%)].  The median usefulness of the test was rated 
at 3 (range 1-9) on a scale of 1 to 10 with 10 being very useful. At least one major shortcoming 
was reported by 97% of the physicians.  These included a low sensitivity (70%), a long time for 
test (37%), low reimbursement (21%), patient discomfort (26%), a low specificity (21%), and no 
added benefit to clinical history (10%).   A majority (68%) felt they rarely or never altered 
treatment based on the results of the tilt test. There was no significant difference in the number 
of tests per physician over the last 12 months between the small (median: 2; range 0-80), 
medium (median: 4, range 0-100) and large institutions (median: 3, range 0-100) (p=ns); 
between the academic (median: 4, range 0-100) and private practice models (median: 2.5, range 
0-80) (p=ns); or between different regions within and outside the United States.                  
Discussion
            The main findings of our survey were that relatively few tilt table tests are being done by 
pediatric EPs and that the majority feels that the frequency of tilt table tests is decreasing in their 
practice. The reasons for these perceptions are unclear but are likely influenced by the perceived 
low usefulness of the test and also the feeling that tilt table testing has numerous shortcomings, a 
notion expressed by almost all of the respondents.                                                     
            We also found wide variation in the testing protocols with an absence of consensus on tilt 
angle, tilt duration, use of pharmacologic agents during the test, and whether patients need to be 
fasting before a test, and if so, for how long. Again the reasons for these differences in protocol 
are   unclear.                                                                        
                Although 95% of the physicians chose a tilt angle between 60 and 80 degrees, there 
was no consensus on a more specific tilt angle within this range.  The positivity rate has been 
shown to be higher at steeper angles (80 vs. 60 degrees)15,17.  In addition, children appear to be 
more susceptible to orthostatic stress than adults and symptoms of pre-syncope and frank 
syncope may be elicited in up to 60% of normal control teenaged volunteers when tilted at an 
angle   of   80   degrees16.                                                                        
            The duration of upright posture is probably the most critical determinant of the sensitivity 
and specificity of the tilt test1. A significant proportion of physicians favored a shorter duration 
of upright posture in children, which is in contrast to most published reports in adults that have 
tended to favor relatively long drug free initial tilt duration of 45 minutes18. Although the longer 
periods may increase the sensitivity of the test, they may be difficult to obtain in children.  
            Isoproterenol and nitroglycerine were the most commonly used pharmacological agents 
in our survey. Oral nitroglycerine has the advantage of performing the test without having to 
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place an intravenous line. However, a recent study comparing nitroglycerin and isoproterenol-
augmented tilt tests in children and adolescents demonstrated that nitroglycerin resulted in more 
false-positive tests and produced more prolonged vasovagal symptoms19.                            
            Fasting prior to the test can impact the result of the test9. Only 19% of the pediatric EPs 
recommend a fasting period over 4 hours prior to the test. The shorter fasting duration may be 
because children may not be able to tolerate longer fasting periods or the potential fear of 
increased false positive tests with the longer fasting conditions.                                     
            These variations in the testing protocols may reflect a lack of conviction on the part of 
pediatric EPS about the usefulness of tilt table testing. Indeed, a majority of respondents (68%) 
reported that the results of the tilt table test rarely influenced therapy.                      
            There are several limitations to our study. The response rate to the survey was only 52%. 
This raises the possibility that only those who felt strongly about tilt table testing may have 
responded to the questionnaire. Because of the blinded nature of the project, we could not 
analyze whether there was a difference between the responders and the non-responders with 
respect to geographic location and the type of practice model. However, in general, all regions 
and institution sizes appeared to be well represented.                                                                    
            Since this study is a survey of physicians and not an investigation of the test itself, we 
cannot draw specific conclusions on the utility, efficacy or accuracy of the test based on this 
data. This study is indicative of the perception of tilt table tests within the pediatric EP 
community. Further studies to investigate the usefulness of this test are necessary.            
Conclusion
            Our survey found that pediatric EPs perceive that tilt table testing is not very useful and 
that it is being used less frequently in children with syncope. We also found significant 
variations in the protocol of testing with a clear lack of standardization. Further studies are 
needed to determine the specific subsets of children with syncope in whom tilt table testing has a 
role in management. We also see the need for the professional societies caring for children (such 
as the American Academy of Pediatrics or the Pediatric and Congenital Electrophysiology 
Society) to come up with a standardized protocol, in the absence of which, this lack of clarity in 
the   field   is   likely   to   continue.                                                               
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